UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020222 |
|---|---|
| Receipt number | R000023357 |
| Scientific Title | A Phase I Trial of Combined immunotherapy with nivolumab and interferon-beta in Patients with advanced melanoma. |
| Date of disclosure of the study information | 2015/12/17 |
| Last modified on | 2017/12/11 19:33:15 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/12/16 15:21:14 | ||
| 2 | Update | 2015/12/21 18:08:48 | Organization Organization |
|
| 3 | Update | 2015/12/24 08:21:53 | Interventions/Control_1 Interventions/Control_1 |
|
| 4 | Update | 2015/12/24 08:25:11 | Primary outcomes Primary outcomes |
|
| 5 | Update | 2016/07/08 11:16:17 | Name of primary person or sponsor Institute Institute Department Organization |
|
| 6 | Update | 2016/07/08 11:18:37 | Recruitment status |
|
| 7 | Update | 2016/12/05 12:34:42 | Last follow-up date Date of closure to data entry Date trial data considered complete Results |
|
| 8 | Update | 2017/12/11 19:33:15 | Recruitment status Publication of results |
